Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Gary L Crocker. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Gary L Crocker har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:MACK / Merrimack Pharmaceuticals, Inc. | See Remarks, Director | 133 105 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Gary L Crocker. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Gary L Crocker som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-08-14 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2 000 | 133 105 | 1,53 | 12,43 | 24 865 | 1 654 841 | |
2023-08-14 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2 000 | 133 105 | 1,53 | 12,52 | 25 039 | 1 666 421 | |
2022-06-13 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4 452 | 131 105 | 3,52 | 5,15 | 22 918 | 674 902 | |
2022-06-09 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 349 | 126 653 | 0,28 | 5,14 | 1 795 | 651 452 | |
2022-06-09 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 300 | 126 304 | 0,24 | 5,05 | 1 515 | 637 835 | |
2022-05-26 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 132 | 126 004 | 0,10 | 5,13 | 678 | 647 005 | |
2022-05-26 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2 323 | 125 872 | 1,88 | 5,09 | 11 817 | 640 298 | |
2022-05-23 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 512 | 123 549 | 0,42 | 5,04 | 2 582 | 623 033 | |
2022-05-19 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5 000 | 123 037 | 4,24 | 5,08 | 25 407 | 625 200 | |
2022-05-19 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 225 | 118 037 | 0,19 | 5,10 | 1 147 | 601 469 | |
2022-05-16 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3 | 117 812 | 0,00 | 4,90 | 15 | 577 279 | |
2022-05-16 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2 471 | 117 809 | 2,14 | 5,04 | 12 456 | 593 863 | |
2022-04-25 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5 000 | 115 338 | 4,53 | 6,00 | 30 001 | 692 051 | |
2022-04-01 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 300 | 110 338 | 0,27 | 6,18 | 1 853 | 681 525 | |
2022-04-01 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 161 | 110 038 | 0,15 | 6,20 | 998 | 682 236 | |
2022-03-29 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5 000 | 109 877 | 4,77 | 6,16 | 30 822 | 677 315 | |
2022-03-24 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 400 | 104 877 | 0,38 | 6,11 | 2 446 | 641 197 | |
2022-03-17 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4 649 | 104 477 | 4,66 | 6,14 | 28 556 | 641 729 | |
2022-03-15 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5 000 | 99 828 | 5,27 | 6,02 | 30 120 | 601 374 | |
2022-03-15 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5 000 | 94 828 | 5,57 | 6,08 | 30 406 | 576 678 | |
2022-02-23 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3 351 | 89 828 | 3,88 | 5,96 | 19 970 | 535 312 | |
2022-02-18 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5 000 | 86 477 | 6,14 | 6,13 | 30 626 | 529 689 | |
2022-02-18 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7 945 | 81 477 | 10,80 | 6,20 | 49 231 | 504 872 | |
2022-02-16 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 123 | 73 532 | 0,17 | 6,20 | 763 | 455 898 | |
2022-02-16 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1 800 | 73 409 | 2,51 | 5,96 | 10 724 | 437 341 | |
2022-01-31 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 673 | 71 609 | 0,95 | 4,60 | 3 096 | 329 401 | |
2022-01-27 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3 100 | 70 936 | 4,57 | 4,56 | 14 121 | 323 128 | |
2022-01-25 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7 105 | 67 836 | 11,70 | 4,33 | 30 741 | 293 506 | |
2022-01-25 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2 000 | 60 731 | 3,41 | 4,65 | 9 310 | 282 691 | |
2022-01-20 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5 000 | 58 731 | 9,31 | 4,54 | 22 690 | 266 515 | |
2022-01-18 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5 000 | 53 731 | 10,26 | 4,51 | 22 554 | 242 364 | |
2022-01-18 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5 000 | 48 731 | 11,43 | 4,42 | 22 120 | 215 591 | |
2022-01-13 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5 000 | 43 731 | 12,91 | 4,33 | 21 658 | 189 425 | |
2022-01-13 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5 000 | 38 731 | 14,82 | 4,03 | 20 140 | 156 012 | |
2021-06-14 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy) |
A - Award | 8 000 | 8 000 | |||||
2021-04-14 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 973 | 33 731 | 2,97 | 6,07 | 5 905 | 204 713 | |
2021-04-12 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1 200 | 32 758 | 3,80 | 6,10 | 7 320 | 199 824 | |
2021-04-09 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2 127 | 31 558 | 7,23 | 6,19 | 13 166 | 195 344 | |
2021-04-01 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 500 | 29 431 | 1,73 | 6,19 | 3 094 | 182 148 | |
2021-03-26 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 200 | 28 931 | 0,70 | 6,13 | 1 226 | 177 347 | |
2021-03-25 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5 000 | 28 731 | 21,07 | 6,34 | 31 690 | 182 097 | |
2021-03-25 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3 627 | 23 731 | 18,04 | 6,47 | 23 455 | 153 461 | |
2021-03-17 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5 000 | 20 104 | 33,10 | 6,79 | 33 956 | 136 530 | |
2021-03-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5 000 | 15 104 | 49,49 | 7,20 | 36 004 | 108 762 | |
2021-02-17 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5 000 | 10 104 | 97,96 | 7,47 | 37 342 | 75 461 | |
2021-02-12 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1 604 | 5 104 | 45,83 | 7,98 | 12 798 | 40 722 | |
2021-02-12 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3 500 | 3 500 | 7,64 | 26 757 | 26 757 | ||
2020-08-03 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy) |
A - Award | 8 000 | 8 000 | |||||
2020-07-24 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
S - Sale | −6 228 | 0 | −100,00 | 3,20 | −19 942 | ||
2020-07-24 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
S - Sale | −17 250 | 0 | −100,00 | 3,20 | −55 234 | ||
2020-07-24 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
S - Sale | −52 068 | 0 | −100,00 | 3,04 | −158 386 | ||
2020-07-24 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
S - Sale | −86 549 | 0 | −100,00 | 3,04 | −263 273 | ||
2020-07-24 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
S - Sale | −8 428 | 0 | −100,00 | 3,20 | −26 986 | ||
2020-07-24 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
S - Sale | −5 986 | 0 | −100,00 | 3,04 | −18 209 | ||
2020-07-24 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
S - Sale | −17 000 | 0 | −100,00 | 3,20 | −54 434 | ||
2019-10-21 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy) |
A - Award | 8 000 | 8 000 | |||||
2018-06-15 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy) |
A - Award | 8 000 | 8 000 | |||||
2017-09-15 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy) |
A - Award | 8 625 | 8 625 | |||||
2016-06-16 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy) |
A - Award | 49 500 | 49 500 | |||||
2015-05-18 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy) |
A - Award | 17 500 | 17 500 | |||||
2015-04-10 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −50 000 | 0 | −100,00 | ||||
2015-04-10 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −35 000 | 0 | −100,00 | ||||
2015-04-10 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
M - Exercise | 50 000 | 2 943 961 | 1,73 | 2,47 | 123 500 | 7 271 584 | |
2015-04-10 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
M - Exercise | 35 000 | 2 893 961 | 1,22 | 1,71 | 59 850 | 4 948 673 | |
2014-11-14 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 8 630 | 2 858 961 | 0,30 | 8,37 | 72 233 | 23 929 504 | |
2014-11-14 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5 760 | 2 850 331 | 0,20 | 8,62 | 49 651 | 24 569 853 | |
2014-06-24 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 36 000 | 2 844 571 | 1,28 | 6,84 | 246 240 | 19 456 866 | |
2014-05-22 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4 000 | 2 808 571 | 0,14 | 6,69 | 26 760 | 18 789 340 | |
2014-05-20 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 6 000 | 2 804 571 | 0,21 | 6,71 | 40 260 | 18 818 671 | |
2014-05-20 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3 400 | 2 798 571 | 0,12 | 6,63 | 22 542 | 18 554 526 | |
2014-05-15 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy) |
A - Award | 37 834 | 37 834 | |||||
2014-05-08 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4 400 | 2 795 171 | 0,16 | 6,77 | 29 788 | 18 923 308 | |
2014-05-07 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7 500 | 2 790 771 | 0,27 | 6,85 | 51 375 | 19 116 781 | |
2014-05-07 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 10 000 | 2 783 271 | 0,36 | 6,92 | 69 200 | 19 260 235 | |
2014-05-06 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −35 000 | 0 | −100,00 | ||||
2014-05-06 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
M - Exercise | 35 000 | 2 773 271 | 1,28 | 1,25 | 43 750 | 3 466 589 | |
2014-05-06 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 10 000 | 2 738 271 | 0,37 | 6,69 | 66 900 | 18 319 033 | |
2014-03-14 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −50 000 | 0 | −100,00 | ||||
2014-03-14 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
M - Exercise | 50 000 | 2 728 271 | 1,87 | 1,25 | 62 500 | 3 410 339 | |
2013-12-02 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 69 000 | 2 678 271 | 2,64 | 3,74 | 257 998 | 10 014 323 | |
2013-12-02 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 69 000 | 2 609 271 | 2,72 | 3,71 | 255 755 | 9 671 524 | |
2013-12-02 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 69 000 | 2 540 271 | 2,79 | 3,71 | 255 783 | 9 416 785 | |
2013-06-13 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy) |
A - Award | 37 834 | 37 834 | |||||
2013-02-13 |
|
5 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
G - Gift | 15 015 | 2 471 271 | 0,61 | ||||
2013-02-13 |
|
5 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
G - Gift | 15 015 | 2 456 256 | 0,62 | ||||
2013-02-13 |
|
5 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
G - Gift | −90 090 | 2 441 241 | −3,56 | ||||
2013-02-13 |
|
5 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
G - Gift | 39 000 | 2 531 331 | 1,56 | ||||
2013-02-13 |
|
5 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
G - Gift | −39 000 | 2 492 331 | −1,54 | ||||
2012-12-17 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 36 500 | 2 531 331 | 1,46 | 6,77 | 247 214 | 17 144 705 | |
2012-09-18 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25 800 | 2 494 831 | 1,04 | 8,34 | 215 172 | 20 806 891 | |
2012-09-18 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 39 000 | 2 469 031 | 1,60 | 8,32 | 324 437 | 20 539 622 | |
2012-08-27 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy) |
A - Award | 31 600 | 31 600 | |||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Series F Convertible Preferred Stock |
C - Conversion | −450 000 | 0 | −100,00 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Series G Convertible Preferred Stock |
C - Conversion | −22 000 | 0 | −100,00 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Series G Convertible Preferred Stock |
C - Conversion | −22 000 | 0 | −100,00 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Series F Convertible Preferred Stock |
C - Conversion | −23 300 | 0 | −100,00 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Series F Convertible Preferred Stock |
C - Conversion | −23 300 | 0 | −100,00 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Series E Convertible Preferred Stock |
C - Conversion | −28 332 | 0 | −100,00 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Series E Convertible Preferred Stock |
C - Conversion | −28 332 | 0 | −100,00 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Series D Convertible Preferred Stock |
C - Conversion | −21 429 | 0 | −100,00 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Series D Convertible Preferred Stock |
C - Conversion | −21 429 | 0 | −100,00 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Series C Convertible Preferred Stock |
C - Conversion | −79 000 | 0 | −100,00 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Series C Convertible Preferred Stock |
C - Conversion | −79 000 | 0 | −100,00 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Series D Convertible Preferred Stock |
C - Conversion | −35 714 | 0 | −100,00 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Series C Convertible Preferred Stock |
C - Conversion | −184 975 | 0 | −100,00 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Series E Convertible Preferred Stock |
C - Conversion | −300 000 | 0 | −100,00 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Series D Convertible Preferred Stock |
C - Conversion | −30 000 | 0 | −100,00 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Series C Convertible Preferred Stock |
C - Conversion | −15 863 | 0 | −100,00 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Series G Convertible Preferred Stock |
C - Conversion | −313 266 | 0 | −100,00 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Series F Convertible Preferred Stock |
C - Conversion | −41 900 | 0 | −100,00 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Series E Convertible Preferred Stock |
C - Conversion | −46 676 | 0 | −100,00 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Series D Convertible Preferred Stock |
C - Conversion | −463 654 | 0 | −100,00 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Series C Convertible Preferred Stock |
C - Conversion | −59 863 | 0 | −100,00 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
C - Conversion | 450 000 | 2 430 031 | 22,73 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
C - Conversion | 22 000 | 1 980 031 | 1,12 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
C - Conversion | 22 000 | 1 980 031 | 1,12 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
C - Conversion | 23 300 | 1 958 031 | 1,20 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
C - Conversion | 23 300 | 1 958 031 | 1,20 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
C - Conversion | 28 332 | 1 934 731 | 1,49 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
C - Conversion | 28 332 | 1 934 731 | 1,49 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
C - Conversion | 21 429 | 1 906 399 | 1,14 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
C - Conversion | 21 429 | 1 906 399 | 1,14 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
C - Conversion | 79 000 | 1 884 970 | 4,37 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
C - Conversion | 79 000 | 1 884 970 | 4,37 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
C - Conversion | 35 714 | 1 631 909 | 2,24 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
C - Conversion | 184 975 | 1 596 195 | 13,11 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
C - Conversion | 300 000 | 1 411 220 | 27,00 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
C - Conversion | 30 000 | 1 111 220 | 2,77 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
C - Conversion | 15 863 | 1 081 220 | 1,49 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
C - Conversion | 313 266 | 1 065 357 | 41,65 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
C - Conversion | 41 900 | 752 091 | 5,90 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
C - Conversion | 46 676 | 710 191 | 7,03 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
C - Conversion | 463 654 | 663 515 | 231,99 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
C - Conversion | 59 863 | 199 861 | 42,76 | ||||
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25 000 | 139 998 | 21,74 | 7,00 | 175 000 | 979 986 | |
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 21 428 | 114 998 | 22,90 | 7,00 | 149 996 | 804 986 | |
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 14 285 | 93 570 | 18,02 | 7,00 | 99 995 | 654 990 | |
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 15 000 | 79 285 | 23,33 | 7,00 | 105 000 | 554 995 | |
2012-04-05 |
|
4 | MACK |
MERRIMACK PHARMACEUTICALS INC
Common Stock |
P - Purchase | 64 285 | 64 285 | 7,00 | 449 995 | 449 995 |